glp1 retatrutide Triple Agonist Peptide | cGMP Retatrutide: GLP-1, GLP-2 & GLP-3

The dosage may be gradually increased over time, depending on how well the medication is tolerated and the desired weight loss goals

GLP-1s are not suitable for patients with certain cancers, severe digestive conditions, or those who are pregnant or breastfeeding

Our weight loss approach focuses on more than just medication

If you have been researching telehealth options for GLP-1 weight loss medications, you have likely encountered IVY RX among the growing number of platforms connecting patients with licensed providers who may prescribe compounded GLP-1 injections

Injection technique All three medications are injected subcutaneously, typically in the abdomen, thigh, or upper arm

In vivo assessment of drug-drug interactions The drug-drug interaction studies were performed at steady state with liraglutide 1.8 mg/day